Welcome to our dedicated page for Gelion news (Ticker: GELNF), a resource for investors and traders seeking the latest updates and insights on Gelion stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Gelion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Gelion's position in the market.
Gelion plc (GELN) has announced a strategic partnership with the Max Planck Institute (MPI) to develop advanced sulfur batteries. The collaboration combines Gelion's battery technology with MPI's breakthrough nano-confined carbon/sulfur composite cathode technology.
Key achievements include successful testing of sodium-sulfur (Na-S) cells demonstrating:
- Long cycle life (hundreds of cycles)
- High-power capabilities (10C)
- Fast-charging under 10 minutes
- Energy density comparable to Lithium Iron Phosphate batteries
Initial testing of lithium-sulfur (Li-S) technology shows promising results with energy density exceeding 400 Wh/kg. The agreement grants Gelion an exclusive option to acquire commercial rights to jointly developed IP during the three-year collaboration period. MPI will dedicate two researchers to the project, with Gelion covering the costs.
